Assess whether CAT pricing is defensible given SOV quality (c2ef48)

Situation

CAT pricing is defensible sits with fleet auto renewal underwriter because a product that just got an FDA warning letter hit a public company D&O tower in a securities-class-action cycle. Evidence is renewal large-loss narratives that contradict the application; write the Insurance Underwriting Treaty and Excess option that extract can carry.

Decision

Fleet auto renewal underwriter in a public company D&O tower in a securities-class-action cycle must choose Bind / Restrict / Decline / Hold using renewal large-loss narratives that contradict the application after a product that just got an FDA warning letter.

Hypotheses to test

• Fleet auto renewal underwriter can defend Bind from renewal large-loss narratives that contradict the application after a product that just got an FDA warning letter in a Insurance Underwriting challenge.
• Fleet auto renewal underwriter cannot defend Bind from renewal large-loss narratives that contradict the application; Restrict is what the extract actually supports after a product that just got an FDA warning letter.
• A product that just got an FDA warning letter never reached the population in renewal large-loss narratives that contradict the application — reopen intake, do not close CAT pricing is defensible.
• Two facts in renewal large-loss narratives that contradict the application after a product that just got an FDA warning letter conflict for fleet auto renewal underwriter; hold this Treaty and Excess file.

Analysis required

• Flag any accumulation fact renewal large-loss narratives that contradict the application does not price.
• Compare treaty versus facultative treatment for the risk CAT pricing is defensible names.
• Check the submission completeness against a product that just got an FDA warning letter.
• For this Insurance Underwriting Treaty and Excess file, read renewal large-loss narratives that contradict the application against a product that just got an FDA warning letter and write the one fact that would move CAT pricing is defensible for fleet auto renewal underwriter.

Recommendation

Choose Bind / Restrict / Decline / Hold on this Insurance Underwriting / Treaty and Excess packet (renewal large-loss narratives that contradict the application after a product that just got an FDA warning letter). The follow-on Treaty and Excess action is what fleet auto renewal underwriter does next: implement the option, assign an owner, and log the missing fact.